Total Valuation
Curanex Pharmaceuticals Inc. has a market cap or net worth of $7.04M. The enterprise value is $5.79M.
Market Cap$7.04M
Enterprise Value$5.79M
Share Statistics
Curanex Pharmaceuticals Inc. has 1,568,241 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,568,241
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Curanex Pharmaceuticals Inc.’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -36.65%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-36.65%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-704.18K
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Curanex Pharmaceuticals Inc. is ―. Curanex Pharmaceuticals Inc.’s PEG ratio is -0.00212.
PE Ratio―
PS Ratio0.00
PB Ratio0.83
Price to Fair Value0.83
Price to FCF-0.89
Price to Operating Cash Flow-0.50
PEG Ratio-0.00212
Income Statement
In the last 12 months, Curanex Pharmaceuticals Inc. had revenue of 0.00 and earned -4.23M in profits. Earnings per share was -2.98.
Revenue0.00
Gross Profit0.00
Operating Income-4.24M
Pretax Income-4.23M
Net Income-4.23M
EBITDA-4.22M
Earnings Per Share (EPS)-2.98
Cash Flow
In the last 12 months, operating cash flow was -12.08M and capital expenditures 0.00, giving a free cash flow of -12.08M billion.
Operating Cash Flow-12.08M
Free Cash Flow-12.08M
Free Cash Flow per Share-7.70
Dividends & Yields
Curanex Pharmaceuticals Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-97.66%
50-Day Moving Average4.33
200-Day Moving Average6.71
Relative Strength Index (RSI)45.61
Average Volume (3m)25.61K
Important Dates
Curanex Pharmaceuticals Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Curanex Pharmaceuticals Inc. as a current ratio of 81.93, with Debt / Equity ratio of 5.77%
Current Ratio81.93
Quick Ratio81.93
Debt to Market Cap0.02
Net Debt to EBITDA1.10
Interest Coverage Ratio-496.55
Taxes
In the past 12 months, Curanex Pharmaceuticals Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Curanex Pharmaceuticals Inc. EV to EBITDA ratio is -1.12, with an EV/FCF ratio of -0.45.
EV to Sales0.00
EV to EBITDA-1.12
EV to Free Cash Flow-0.45
EV to Operating Cash Flow-0.45
Balance Sheet
Curanex Pharmaceuticals Inc. has $2.94M in cash and marketable securities with $276.36K in debt, giving a net cash position of $2.66M billion.
Cash & Marketable Securities$2.94M
Total Debt$276.36K
Net Cash$2.66M
Net Cash Per Share$1.70
Tangible Book Value Per Share$7.92
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Curanex Pharmaceuticals Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-2256.41%